GSK to make 13,500 malaria compounds freely available

GlaxoSmithKline is to make 13,500 potential malaria compounds freely available to researchers from around the world in a bid to stimulate work on medicines for the developing world. It is also allocating $8 million to a new research foundation.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom